Drug recall · September 3, 2025
Lisdexamfetamine Dimesylate Capsules recall
Why: Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37
- Lots / codes
Lot #: 25280726A, Exp. Date 03/2027
- Quantity
- 8544 bottles
- Company
- Lannett Company Inc., Seymour, IN
- Distribution
- Nationwide within the USA
- Initiated
- August 11, 2025 · Voluntary: Firm initiated
- Classified
- August 25, 2025
- Reported
- September 3, 2025
- Ended
- June 24, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lisdexamfetamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.